Influenza Vaccine Dosing Schedule for Infants
Infants should begin influenza vaccination at 6 months of age with either a 0.25 mL or 0.5 mL dose (depending on the specific vaccine product), and first-time recipients require 2 doses administered at least 4 weeks apart, ideally completed by the end of October. 1
Age Eligibility and Timing
- Influenza vaccination is recommended for all infants starting at 6 months of age and older 1, 2
- Vaccination is not licensed for infants younger than 6 months 3
- Household contacts and caregivers of infants under 6 months should be vaccinated to provide indirect protection through "cocooning" 4
- Vaccination should begin as soon as vaccine becomes available in early fall, with both doses ideally completed by the end of October for optimal protection before peak influenza season 1, 5
Dose Volume by Product (6-35 Months)
The specific dose volume varies by vaccine manufacturer: 1, 5
- Afluria (Seqirus): 0.25 mL per dose
- Fluzone (Sanofi Pasteur): Either 0.25 mL or 0.5 mL per dose (both demonstrated comparable safety and immunogenicity) 4
- Fluarix (GlaxoSmithKline): 0.5 mL per dose
- FluLaval (GlaxoSmithKline): 0.5 mL per dose
- Flucelvax (Seqirus): 0.5 mL per dose
Two-Dose Schedule for First-Time Recipients
Children 6 months through 8 years receiving influenza vaccine for the first time require 2 doses: 1
- Minimum interval between doses: at least 4 weeks apart 1, 2
- Doses given up to 4 days before the minimum interval are acceptable 1
- Children who received only 1 dose before July 1 of the current season also require 2 doses 1
- Children whose vaccination status is unknown should receive 2 doses 1
Single-Dose Schedule for Previously Vaccinated
Children who have received 2 or more total doses of influenza vaccine (at any time in their life, not necessarily in consecutive seasons) require only 1 dose in subsequent seasons 1, 2
Route of Administration
- Administer intramuscularly into the anterolateral thigh for infants 5, 3
- The vaccine should be clear and slightly opalescent; inspect for particulate matter before administration 3
- Shake the prefilled syringe or multi-dose vial before administering each dose 3
Vaccine Product Selection
- Any licensed, age-appropriate influenza vaccine can be used; no specific product is preferred over another 1
- The two doses in a season do not need to be the same brand 1
- Vaccination should not be delayed to obtain a specific product 1
- Only inactivated influenza vaccine (IIV) is appropriate for infants 6-23 months; live attenuated influenza vaccine (LAIV) is not licensed for children under 2 years 2, 6
Common Pitfalls to Avoid
- Delaying the second dose beyond the recommended interval leaves the infant inadequately protected during peak season 4
- Using incorrect dosage based on age and specific vaccine product 4
- Not completing the two-dose series for first-time recipients, which is essential for adequate immunity 4
- Splitting a 0.5 mL dose into two 0.25 mL doses is not acceptable 1
- Waiting for a specific vaccine brand when any age-appropriate product is available 1
Special Considerations for High-Risk Infants
- Infants with chronic medical conditions (cardiac disease, asthma, immunocompromise) should be prioritized for vaccination 1
- Reaction rates may be higher when administered with other routine vaccines, but this should not delay vaccination 4
- The most common adverse reactions in infants 6-35 months are pain/tenderness (>50%), redness (>25%), irritability and drowsiness (>25%) 1